We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

From fetal tendon regeneration to adult therapeutic modalities: TGF-β3 in scarless healing

    Hanyue Li

    School of Physical Education, Southwest Medical University, Luzhou, China

    ,
    Shengyu Luo

    School of Physical Education, Southwest Medical University, Luzhou, China

    ,
    Hongtao Li

    Department of Spinal Surgery, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Sichuan, China

    ,
    Hongyu Pan

    Department of Spinal Surgery, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Sichuan, China

    ,
    Li Jiang

    School of Physical Education, Southwest Medical University, Luzhou, China

    ,
    Yixuan Chen

    School of Physical Education, Southwest Medical University, Luzhou, China

    ,
    Hui Chen

    Geriatric department, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Sichuan, China

    ,
    Zhenhua Feng

    Division of Spine Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University

    &
    Sen Li

    *Author for correspondence:

    E-mail Address: jht187@163.com

    School of Physical Education, Southwest Medical University, Luzhou, China

    Published Online:https://doi.org/10.2217/rme-2023-0145

    Tendon injuries are common disorders that can significantly impact people’s lives. Unfortunately, the limited regenerative ability of tendons results in tissue healing in a scar-mediated manner. The current therapeutic strategies fail to fully recover the functions of the injured tendons, and as such, the conception of ‘scarless healing’ has gained prominent attention in the field of regenerative medicine. Interestingly, injured fetal tendons possess the capability to heal through regeneration, which builds an ideal blueprint for adult tendon regeneration. Studies have shown that fetal biochemical cues have the potential to improve adult tendon healing. Here we review the biological factors that contribute to fetal tendon regeneration and how manipulation of these biochemical cues in the adult tendon healing process could achieve regeneration.

    Plain language summary

    We reviewed the biological factors that contribute to fetal tendon regeneration and how manipulation of these biochemical cues in the adult tendon healing process could achieve regeneration. The results showed that inflammation and TGF-β level are the main elements involved in fetal tendon regeneration. Experimental manipulation of these biochemical cues in the adult tendon healing process demonstrated that although the blockade of TGF-β1, TGF-β2 and inflammation reduced scar tissue in adult tendon healing, this inhibition also destroyed the mechanical properties of the tendons. An effective alternative is regulating the specific downstream profibrotic effectors of both TGF-β1 and inflammation, which is preferable to those that completely inhibit these factors. Finally, TGF-β3 is a master regulator allowing a shift from adult scar healing to scarless healing, and the administration of TGF-β3 is a viable strategy to promote adult regenerative healing. In terms of mechanisms, TGF-β3 can activate Smad7 and inhibit the JNK/c-Jun signaling pathway to promote tendon regenerative healing.

    References

    • 1. Andia I, Sanchez M, Maffulli N. Tendon healing and platelet-rich plasma therapies. Expert Opin. Biol. Ther. 10(10), 1415–1426 (2010).
    • 2. Clayton RA, Court-Brown CM. The epidemiology of musculoskeletal tendinous and ligamentous injuries. Injury 39(12), 1338–1344 (2008).
    • 3. Sharma P, Maffulli N. Tendon injury and tendinopathy: healing and repair. J. Bone Joint Surg. Am. 87(1), 187–202 (2005).
    • 4. Voleti PB, Buckley MR, Soslowsky LJ. Tendon healing: repair and regeneration. Annu. Rev. Biomed. Eng. 14, 47–71 (2012).
    • 5. Sharma P, Maffulli N. The future: rehabilitation, gene therapy, optimization of healing. Foot Ankle Clin. 10(2), 383–397 (2005).
    • 6. Fu S, Lan Y, Wang G et al. External stimulation: a potential therapeutic strategy for tendon–bone healing. Front. Bioeng. Biotechnol. 11, 1150290 (2023).
    • 7. Lui P, Zhang P, Chan K, Qin L. Biology and augmentation of tendon-bone insertion repair. J. Orthop. Surg. Res. 5, 59 (2010).
    • 8. Titan AL, Foster DS, Chang J, Longaker MT. Flexor tendon: development, healing, adhesion formation, and contributing growth factors. Plast. Reconstr. Surg. 144(4), 639e–647e (2019).
    • 9. Klifto CS, Capo JT, Sapienza A, Yang SS, Paksima N. Flexor tendon injuries. J. Am. Acad. Orthop. Surg. 26(2), e26–e35 (2018).
    • 10. Docheva D, Muller SA, Majewski M, Evans CH. Biologics for tendon repair. Adv. Drug Deliv. Rev. 84 222–239 (2015).
    • 11. Chung B, Wiley JP. Extracorporeal shockwave therapy: a review. Sports Med. 32(13), 851–865 (2002).
    • 12. Barboni B, Curini V, Russo V et al. Indirect co-culture with tendons or tenocytes can program amniotic epithelial cells towards stepwise tenogenic differentiation. PLoS ONE 7(2), e30974 (2012).
    • 13. Ferguson MW, O’Kane S. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos. Trans. R. Soc. Lond. B Biol. Sci. 359(1445), 839–850 (2004).
    • 14. Namba RS, Meuli M, Sullivan KM, Le AX, Adzick NS. Spontaneous repair of superficial defects in articular cartilage in a fetal lamb model. J. Bone Joint Surg. Am. 80(1), 4–10 (1998).
    • 15. Slate RK, Posnick JC, Wells MD, Goldstein JA, Keeley FW, Thorner PS. Fetal tibial bone healing in utero: the effects of miniplate fixation. Plast. Reconstr. Surg. 92(5), 874–883 (1993).
    • 16. Coolen NA, Schouten KC, Boekema BK, Middelkoop E, Ulrich MM. Wound healing in a fetal, adult, and scar tissue model: a comparative study. Wound Repair Regen. 18(3), 291–301 (2010).
    • 17. Beredjiklian PK, Favata M, Cartmell JS, Flanagan CL, Crombleholme TM, Soslowsky LJ. Regenerative versus reparative healing in tendon: a study of biomechanical and histological properties in fetal sheep. Ann. Biomed. Eng. 31(10), 1143–1152 (2003).
    • 18. Favata M, Beredjiklian PK, Zgonis MH et al. Regenerative properties of fetal sheep tendon are not adversely affected by transplantation into an adult environment. J. Orthop. Res. 24(11), 2124–2132 (2006).
    • 19. Al-Qattan MM, Posnick JC, Lin KY, Thorner P. Fetal tendon healing: development of an experimental model. Plast. Reconstr. Surg. 92(6), 1155–1160; discussion 1161 (1993).
    • 20. Al-Qattan MM, Posnick JC, Lin KY. The in vivo response of foetal tendons to sutures. J. Hand Surg. 20(3), 314–318 (1995).
    • 21. Ribitsch I, Bileck A, Aldoshin AD et al. Molecular mechanisms of fetal tendon regeneration versus adult fibrous repair. Int. J. Mol. Sci. 22(11), 5619 (2021).
    • 22. Galatz LM, Gerstenfeld L, Heber-Katz E, Rodeo SA. Tendon regeneration and scar formation: the concept of scarless healing. J. Orthop. Res. 33(6), 823–831 (2015).
    • 23. Degen KE, Gourdie RG. Embryonic wound healing: a primer for engineering novel therapies for tissue repair. Birth Defects Res. C Embryo Today 96(3), 258–270 (2012).
    • 24. Ackerman JE, Best KT, Muscat SN, Loiselle AE. Metabolic regulation of tendon inflammation and healing following injury. Curr. Rheumatol. Rep. 23(3), 15 (2021).
    • 25. Dakin SG, Martinez FO, Yapp C et al. Inflammation activation and resolution in human tendon disease. Sci. Transl. Med. 7(311), 311ra173 (2015).
    • 26. Godbout C, Bilodeau R, Van Rooijen N, Bouchard P, Frenette J. Transient neutropenia increases macrophage accumulation and cell proliferation but does not improve repair following intratendinous rupture of Achilles tendon. J. Orthop. Res. 28(8), 1084–1091 (2010).
    • 27. Korcari A, Buckley MR, Loiselle AE. Characterization of scar tissue biomechanics during adult murine flexor tendon healing. J. Mech. Behav. Biomed. Mater. 130, 105192 (2022).
    • 28. Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 6, 13 (2014).
    • 29. Muller SA, Todorov A, Heisterbach PE, Martin I, Majewski M. Tendon healing: an overview of physiology, biology, and pathology of tendon healing and systematic review of state of the art in tendon bioengineering. Knee Surg. Sports Traumatol. Arthrosc. 23(7), 2097–2105 (2015).
    • 30. Andarawis-Puri N, Flatow EL. Promoting effective tendon healing and remodeling. J. Orthop. Res. 36(12), 3115–3124 (2018).
    • 31. Maffulli N, Moller HD, Evans CH. Tendon healing: can it be optimised? Br. J. Sports Med. 36(5), 315–316 (2002).
    • 32. Murrell GA. Oxygen free radicals and tendon healing. J. Shoulder Elbow Surg. 16(Suppl. 5), S208–S214 (2007).
    • 33. Nichols AEC, Best KT, Loiselle AE. The cellular basis of fibrotic tendon healing: challenges and opportunities. Transl. Res. 209, 156–168 (2019).
    • 34. Baddour JA, Sousounis K, Tsonis PA. Organ repair and regeneration: an overview. Birth Defects Res. C Embryo Today 96(1), 1–29 (2012).
    • 35. Nguyen PK, Hart C, Hall K, Holt I, Kuo CK. Establishing in vivo and ex vivo chick embryo models to investigate fetal tendon healing. Sci. Rep. 13(1), 9600 (2023).
    • 36. Lichtman MK, Otero-Vinas M, Falanga V. Transforming growth factor beta (TGF-beta) isoforms in wound healing and fibrosis. Wound Repair Regen. 24(2), 215–222 (2016).
    • 37. Bayer ML, Yeung CY, Kadler KE et al. The initiation of embryonic-like collagen fibrillogenesis by adult human tendon fibroblasts when cultured under tension. Biomaterials 31(18), 4889–4897 (2010).
    • 38. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433(7027), 760–764 (2005).
    • 39. Herdrich BJ, Danzer E, Davey MG et al. Fetal tendon wound size modulates wound gene expression and subsequent wound phenotype. Wound Repair Regen. 18(5), 543–549 (2010).
    • 40. Eming SA, Hammerschmidt M, Krieg T, Roers A. Interrelation of immunity and tissue repair or regeneration. Semin. Cell Dev. Biol. 20(5), 517–527 (2009).
    • 41. Kuo CK, Petersen BC, Tuan RS. Spatiotemporal protein distribution of TGF-betas, their receptors, and extracellular matrix molecules during embryonic tendon development. Dev. Dyn. 237(5), 1477–1489 (2008).
    • 42. Pryce BA, Watson SS, Murchison ND, Staverosky JA, Dunker N, Schweitzer R. Recruitment and maintenance of tendon progenitors by TGFbeta signaling are essential for tendon formation. Development 136(8), 1351–1361 (2009).
    • 43. Kohama K, Nonaka K, Hosokawa R, Shum L, Ohishi M. TGF-beta-3 promotes scarless repair of cleft lip in mouse fetuses. J. Dent. Res. 81(10), 688–694 (2002).
    • 44. Hakvoort T, Altun V, Van Zuijlen PP, De Boer WI, Van Schadewij WA, Van Der Kwast TH. Transforming growth factor-beta(1), -beta(2), -beta(3), basic fibroblast growth factor and vascular endothelial growth factor expression in keratinocytes of burn scars. Eur. Cytokine Netw. 11(2), 233–239 (2000).
    • 45. Soo C, Beanes SR, Hu FY et al. Ontogenetic transition in fetal wound transforming growth factor-beta regulation correlates with collagen organization. Am. J. Pathol. 163(6), 2459–2476 (2003).
    • 46. Colwell AS, Longaker MT, Peter Lorenz H. Identification of differentially regulated genes in fetal wounds during regenerative repair. Wound Repair Regen. 16(3), 450–459 (2008).
    • 47. Antman EM. Evaluating the cardiovascular safety of nonsteroidal anti-inflammatory drugs. Circulation 135(21), 2062–2072 (2017).
    • 48. Ferry ST, Dahners LE, Afshari HM, Weinhold PS. The effects of common anti-inflammatory drugs on the healing rat patellar tendon. Am. J. Sports Med. 35(8), 1326–1333 (2007).
    • 49. Connizzo BK, Yannascoli SM, Tucker J et al. The detrimental effects of systemic ibuprofen delivery on tendon healing are time-dependent. Clin. Orthop. Relat. Res. 472(8), 2433–2439 (2014).
    • 50. Tsai WC, Hsu CC, Chen CP, Chen MJ, Lin MS, Pang JH. Ibuprofen inhibition of tendon cell migration and down-regulation of paxillin expression. J. Orthop. Res. 24(3), 551–558 (2006).
    • 51. Tsai WC, Hsu CC, Chou SW, Chung CY, Chen J, Pang JH. Effects of celecoxib on migration, proliferation and collagen expression of tendon cells. Connect. Tissue Res. 48(1), 46–51 (2007).
    • 52. Chang J, Thunder R, Most D, Longaker MT, Lineaweaver WC. Studies in flexor tendon wound healing: neutralizing antibody to TGF-beta1 increases postoperative range of motion. Plast. Reconstr. Surg. 105(1), 148–155 (2000).
    • 53. Xia C, Yang X, Wang YZ, Sun K, Ji L, Tian S. Tendon healing in vivo and in vitro: neutralizing antibody to TGF-beta improves range of motion after flexor tendon repair. Orthopedics 33(11), 809 (2010).
    • 54. Chen CH, Zhou YL, Wu YF, Cao Y, Gao JS, Tang JB. Effectiveness of microRNA in down-regulation of TGF-beta gene expression in digital flexor tendons of chickens: in vitro and in vivo study. J. Hand Surg. 34(10), 1777–1784; e1771 (2009).
    • 55. Wang XT, Liu PY, Tang JB et al. Tendon healing in vitro: adeno-associated virus-2 effectively transduces intrasynovial tenocytes with persistent expression of the transgene, but other serotypes do not. Plast. Reconstr. Surg. 119(1), 227–234 (2007).
    • 56. Wu YF, Mao WF, Zhou YL, Wang XT, Liu PY, Tang JB. Adeno-associated virus-2-mediated TGF-beta1 microRNA transfection inhibits adhesion formation after digital flexor tendon injury. Gene Ther. 23(2), 167–175 (2016).
    • 57. Zhou Y, Zhang L, Zhao W, Wu Y, Zhu C, Yang Y. Nanoparticle-mediated delivery of TGF-beta1 miRNA plasmid for preventing flexor tendon adhesion formation. Biomaterials 34(33), 8269–8278 (2013).
    • 58. Kim HM, Galatz LM, Das R, Havlioglu N, Rothermich SY, Thomopoulos S. The role of transforming growth factor beta isoforms in tendon-to-bone healing. Connect. Tissue Res. 52(2), 87–98 (2011).
    • 59. Farhat YM, Al-Maliki AA, Chen T et al. Gene expression analysis of the pleiotropic effects of TGF-beta1 in an in vitro model of flexor tendon healing. PLoS ONE 7(12), e51411 (2012).
    • 60. Tsubone T, Moran SL, Subramaniam M, Amadio PC, Spelsberg TC, An KN. Effect of TGF-beta inducible early gene deficiency on flexor tendon healing. J. Orthop. Res. 24(3), 569–575 (2006).
    • 61. Gill SE, Parks WC. Metalloproteinases and their inhibitors: regulators of wound healing. Int. J. Biochem. Cell Biol. 40(6-7), 1334–1347 (2008).
    • 62. Farhat YM, Al-Maliki AA, Easa A, O’Keefe RJ, Schwarz EM, Awad HA. TGF-beta1 suppresses plasmin and MMP activity in flexor tendon cells via PAI-1: implications for scarless flexor tendon repair. J. Cell. Physiol. 230(2), 318–326 (2015).
    • 63. Ghosh AK, Vaughan DE. PAI-1 in tissue fibrosis. J. Cell. Physiol. 227(2), 493–507 (2012).
    • 64. Freeberg MaT, Farhat YM, Easa A et al. Serpine1 knockdown enhances MMP activity after flexor tendon injury in mice: implications for adhesions therapy. Sci. Rep. 8(1), 5810 (2018).
    • 65. Cetik RM, Yabanoglu Ciftci S, Arica B et al. Evaluation of the effects of transforming growth factor-beta 3 (TGF-beta3) loaded nanoparticles on healing in a rat Achilles tendon injury model. Am. J. Sports Med. 50(4), 1066–1077 (2022).
    • 66. Manning CN, Kim HM, Sakiyama-Elbert S, Galatz LM, Havlioglu N, Thomopoulos S. Sustained delivery of transforming growth factor beta three enhances tendon-to-bone healing in a rat model. J. Orthop. Res. 29(7), 1099–1105 (2011).
    • 67. Han B, Jones IA, Yang Z, Fang W, Vangsness CT Jr. Repair of rotator cuff tendon defects in aged rats using a growth factor injectable gel scaffold. Arthroscopy 36(3), 629–637 (2020).
    • 68. Reifenrath J, Wellmann M, Kempfert M et al. TGF-beta3 loaded electrospun polycaprolacton fibre scaffolds for rotator cuff tear repair: an in vivo study in rats. Int. J. Mol. Sci. 21(3), 1046 (2020).
    • 69. Kovacevic D, Fox AJ, Bedi A et al. Calcium–phosphate matrix with or without TGF-beta3 improves tendon-bone healing after rotator cuff repair. Am. J. Sports Med. 39(4), 811–819 (2011).
    • 70. Zi Z. Molecular engineering of the TGF-beta signaling pathway. J. Mol. Biol. 431(15), 2644–2654 (2019).
    • 71. Xu P, Liu J, Derynck R. Post-translational regulation of TGF-beta receptor and Smad signaling. FEBS Lett. 586(14), 1871–1884 (2012).
    • 72. Peng D, Fu M, Wang M, Wei Y, Wei X. Targeting TGF-beta signal transduction for fibrosis and cancer therapy. Mol. Cancer 21(1), 104 (2022).
    • 73. Hata A, Chen YG. TGF-beta signaling from receptors to Smads. Cold Spring Harb. Perspect. Biol. 8(9), a022061 (2016).
    • 74. Morikawa M, Derynck R, Miyazono K. TGF-beta and the TGF-beta family: context-dependent roles in cell and tissue physiology. Cold Spring Harb. Perspect. Biol. 8(5), a021873 (2016).
    • 75. Larson C, Oronsky B, Carter CA et al. TGF-beta: a master immune regulator. Expert Opin. Ther. Targets 24(5), 427–438 (2020).
    • 76. Jiang K, Li Y, Xiang C, Xiong Y, Jia J. Rebalancing SMAD7/SMAD3 signaling reduces adhesion formation during flexor tendon healing. J. Microbiol. Biotechnol. 33(3), 339–347 (2023).
    • 77. Katzel EB, Wolenski M, Loiselle AE et al. Impact of Smad3 loss of function on scarring and adhesion formation during tendon healing. J. Orthop. Res. 29(5), 684–693 (2011).
    • 78. Wu LM, Wang JK, Liu J, Fan CC, Wang YJ, Xiong Y. Gait analysis combined with the expression of TGF-beta1, TGF-beta3 and CREB during Achilles tendon healing in rat. Chin. J. Traumatol. 24(6), 360–367 (2021).
    • 79. Jiang K, Chun G, Wang Z, Du Q, Wang A, Xiong Y. Effect of transforming growth factor-beta3 on the expression of Smad3 and Smad7 in tenocytes. Mol. Med. Rep. 13(4), 3567–3573 (2016).
    • 80. Lee SY, Lee MH, Jo SK et al. Effects and mechanism of particulate matter on tendon healing based on integrated analysis of DNA methylation and RNA sequencing data in a rat model. Int. J. Mol. Sci. 23(15), 8170 (2022).
    • 81. Liu G, Ding W, Neiman J, Mulder KM. Requirement of Smad3 and CREB-1 in mediating transforming growth factor-beta (TGF beta) induction of TGF beta 3 secretion. J. Biol. Chem. 281(40), 29479–29490 (2006).
    • 82. Rho JH, Ko IG, Jin J et al. Polydeoxyribonucleotide ameliorates inflammation and apoptosis in Achilles tendon-injury rats. Int. Neurourol. J. 24(Suppl. 2), 79–87 (2020).
    • 83. Wu LM, Wang YJ, Li SF et al. Up-regulation of CREB-1 regulates tendon adhesion in the injury tendon healing through the CREB-1/TGF-beta3 signaling pathway. BMC Musculoskelet. Disord. 24(1), 325 (2023).
    • 84. Tao Y, Zhou X, Liang C et al. TGF-beta3 and IGF-1 synergy ameliorates nucleus pulposus mesenchymal stem cell differentiation towards the nucleus pulposus cell type through MAPK/ERK signaling. Growth Factors 33(5-6), 326–336 (2015).
    • 85. Low HB, Zhang Y. Regulatory roles of MAPK phosphatases in cancer. Immune Netw. 16(2), 85–98 (2016).
    • 86. Wada T, Penninger JM. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23(16), 2838–2849 (2004).
    • 87. Suchal K, Malik S, Gamad N et al. Mangiferin protect myocardial insults through modulation of MAPK/TGF-beta pathways. Eur. J. Pharmacol. 776, 34–43 (2016).
    • 88. Wang Y, He G, Tang H et al. Aspirin inhibits inflammation and scar formation in the injury tendon healing through regulating JNK/STAT-3 signalling pathway. Cell Prolif. 52(4), e12650 (2019).
    • 89. Shen H, Jayaram R, Yoneda S et al. The effect of adipose-derived stem cell sheets and CTGF on early flexor tendon healing in a canine model. Sci. Rep. 8(1), 11078 (2018).
    • 90. Jiang K, Li Y, Xiang C, Xiong Y, Jia J. TGF-beta3 regulates adhesion formation through the JNK/c-Jun pathway during flexor tendon healing. BMC Musculoskelet. Disord. 22(1), 843 (2021).
    • 91. Best KT, Nichols AEC, Knapp E et al. NF-kappaB activation persists into the remodeling phase of tendon healing and promotes myofibroblast survival. Sci. Signal. 13(658), eabb7209 (2020).
    • 92. Campbell BH, Agarwal C, Wang JH. TGF-beta1, TGF-beta3, and PGE(2) regulate contraction of human patellar tendon fibroblasts. Biomech. Model. Mechanobiol. 2(4), 239–245 (2004).
    • 93. Chan KM, Fu SC, Wong YP, Hui WC, Cheuk YC, Wong MW. Expression of transforming growth factor beta isoforms and their roles in tendon healing. Wound Repair Regen. 16(3), 399–407 (2008).
    • 94. Gumucio JP, Sugg KB, Mendias CL. TGF-beta superfamily signaling in muscle and tendon adaptation to resistance exercise. Exerc. Sport Sci. Rev. 43(2), 93–99 (2015).
    • 95. Wang X, Li F, Xie L et al. Inhibition of overactive TGF-beta attenuates progression of heterotopic ossification in mice. Nat. Commun. 9(1), 551 (2018).